139 related articles for article (PubMed ID: 18307245)
1. Emotional speech in Parkinson's disease.
Möbes J; Joppich G; Stiebritz F; Dengler R; Schröder C
Mov Disord; 2008 Apr; 23(6):824-9. PubMed ID: 18307245
[TBL] [Abstract][Full Text] [Related]
2. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
Skodda S; Rinsche H; Schlegel U
Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
[TBL] [Abstract][Full Text] [Related]
3. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
[TBL] [Abstract][Full Text] [Related]
4. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
5. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
[TBL] [Abstract][Full Text] [Related]
6. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
7. Vocal emotion processing in Parkinson's disease: reduced sensitivity to negative emotions.
Dara C; Monetta L; Pell MD
Brain Res; 2008 Jan; 1188():100-11. PubMed ID: 18022608
[TBL] [Abstract][Full Text] [Related]
8. Prosody and levodopa in Parkinson's disease.
Azevedo LL; Reis CA; Souza IS; Cardoso FE
Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
[TBL] [Abstract][Full Text] [Related]
9. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
Goberman AM
Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
[TBL] [Abstract][Full Text] [Related]
10. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
[TBL] [Abstract][Full Text] [Related]
11. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
[TBL] [Abstract][Full Text] [Related]
12. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
[TBL] [Abstract][Full Text] [Related]
13. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
Skodda S; Grönheit W; Schlegel U
J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
[TBL] [Abstract][Full Text] [Related]
14. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
Okada Y; Murata M; Toda T
Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
[TBL] [Abstract][Full Text] [Related]
15. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
[TBL] [Abstract][Full Text] [Related]
16. Speech rate in Parkinson's disease: A controlled study.
Martínez-Sánchez F; Meilán JJ; Carro J; Gómez Íñiguez C; Millian-Morell L; Pujante Valverde IM; López-Alburquerque T; López DE
Neurologia; 2016 Sep; 31(7):466-72. PubMed ID: 25660139
[TBL] [Abstract][Full Text] [Related]
17. Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease.
Rektorova I; Barrett J; Mikl M; Rektor I; Paus T
Mov Disord; 2007 Oct; 22(14):2043-51. PubMed ID: 17683056
[TBL] [Abstract][Full Text] [Related]
18. For better or worse: The effect of levodopa on speech in Parkinson's disease.
Ho AK; Bradshaw JL; Iansek R
Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
[TBL] [Abstract][Full Text] [Related]
19. Perception of emotional speech in Parkinson's disease.
Schröder C; Möbes J; Schütze M; Szymanowski F; Nager W; Bangert M; Münte TF; Dengler R
Mov Disord; 2006 Oct; 21(10):1774-8. PubMed ID: 16830324
[TBL] [Abstract][Full Text] [Related]
20. Emotional processing in Parkinson's disease. A study using functional transcranial doppler sonography.
Troisi E; Peppe A; Pierantozzi M; Matteis M; Vernieri F; Stanzione P; Silvestrini M; Caltagirone C
J Neurol; 2002 Aug; 249(8):993-1000. PubMed ID: 12195443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
